Bomi Framroze

Bomi Framroze has a diverse work experience spanning over several decades. Their most recent position was as the Chief Scientific Officer at Hofseth BioCare ASA since September 2010. They also served as a Visiting Scholar at Stanford University Department of Pediatrics starting from January 2022.

Bomi previously held leadership roles at GPH Biotech LLC and Supportive Therapeutics, where they served as Chief Scientific Officer. Prior to that, they were the CSO and President at Row2Technologies Inc from April 2000 to January 2004.

They have also worked as the Executive Director, Technical at GHARDA CHEMICALS LIMITED and Technical Director at Gharda Polymers from 1996 to 2000.

Earlier in their career, Bomi held roles at American Cyanamid as Associate Director, Chemical Discovery from April 1994 to May 1996, Group Leader from 1990 to 1994, and Senior Research Scientist from August 1987 to March 1990.

Bomi's educational background includes being a Graduate Student at Bryn Mawr College from 1984 to 1987.

Bomi Framroze has a strong education background in the field of Chemistry. They began their undergraduate studies in 1979 at St. Xavier's College, where they earned a Bachelor of Science (BSc) degree with a focus on Chemistry. During the same period, from 1979 to 1982, they attended the University of Mumbai and obtained a Bachelor of Science (Hons) degree with a double major in Chemistry and Mathematics.

After completing their undergraduate studies, Bomi pursued further education and enrolled at the University of Pennsylvania in 1982. They completed a Master of Science (MS) degree in Chemistry between 1982 and 1984.

Following their master's program, Bomi attended Bryn Mawr College from 1984 to 1987. At Bryn Mawr College, they successfully completed their doctoral studies and obtained a PhD in Organic Chemistry.

Overall, Bomi Framroze's educational background showcases a progression from undergraduate studies to a master's degree and ultimately a Ph.D. The majority of their academic focus was on Chemistry, with a significant emphasis on organic chemistry during their doctoral studies.